Management of donors and blood products reactive for hepatitis B virus DNA

Vox Sanguinis

Volumn 91, Issue 4, 2006, Pages 281-

  Reesink, H W ^a   Allain, J P ^b  

^a Sanquin Bloedbank Regio Noordwest Amsterdam   (Netherlands)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; VIRUS DNA; VIRUS RNA;

ANTIBODY SCREENING; ANTIBODY TITER; BLOOD; BLOOD ANALYSIS; BLOOD DONOR; BLOOD TRANSFUSION; EDITORIAL; FOOD AND DRUG ADMINISTRATION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HIGH THROUGHPUT SCREENING; HUMAN; NUCLEIC ACID AMPLIFICATION; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS LOAD;

BLOOD; BLOOD BANKS; BLOOD DONORS; BLOOD TRANSFUSION; DNA, VIRAL; HEPATITIS B VIRUS; HUMANS; MASS SCREENING; PRACTICE GUIDELINES;

EID: 33750851695     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2006.00843.x     Document Type: Editorial

References (5)

1. Lucey C: Brief report on the United States Food and Drug Administration Blood Products Advisory Committee recommendations for management of donors and units testing positive for hepatitis B virus DNA. Vox Sang 2006; 91:331-335
2. US Food and Drug Administration. Transcript of the 83rd Meeting of the Blood Products Advisory Committee. [cited 23 Mar 2006]. Available from http://www.fda.gov/ohrms/dockets/ac/05/transcripts/2005-4164t1.htm
3. US Food and Drug Administration. Federal Register: 1 July 2005, Volume 70, Number 126, Notices, Page 38182-38183 [cited 01 July 2006]. Available from: http://www.fda.gov/ohrms/dockets/98fr/05-13017.htm
4. Allain J-P, Reesink HW, Lucey C: A European perspective on the management of donors and units testing positive for hepatitis B virus DNA. Transfusion 2006; 46:1256-1258
5. Dreier J, Kroger M, Diekmann J, Gotting C, Kleesiek K: Intermittent HBV viremia in an anti-HBc and anti-HBs-positive blood donor. Transf Med 2005; 15:65-66